enVVeno Medical Corporation (NVNO) Financials

NVNO Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 29.6 million 2.4 million
Sept. 30, 2025 32.4 million 2.9 million
June 30, 2025 36.6 million 3.5 million
March 31, 2025 40.6 million 2.3 million

NVNO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 -3.4 million 637000
Sept. 30, 2025 -4.4 million 239117
June 30, 2025 -3.7 million 1.9 million
March 31, 2025 -4.0 million 651000

NVNO Net Income

No data available :(

NVNO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 28.2 million - 310000
Sept. 30, 2025 31.0 million - 791000
June 30, 2025 35.1 million - 882000
March 31, 2025 38.9 million - 979000

NVNO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 589000
Sept. 30, 2025 16453
June 30, 2025 16614
March 31, 2025 16614

NVNO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 - 1.9 million 2.1 million -
Sept. 30, 2025 5000 2.6 million 2.2 million -
June 30, 2025 5000 2.9 million 4.0 million -
March 31, 2025 5000 2.6 million 2.3 million -

NVNO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 - 117000
Sept. 30, 2025 - 120000
June 30, 2025 - 130000
March 31, 2025 - 122000

NVNO Revenue by Segment
Graph available only for paid members. Upgrade to see it.

NVNO

Price: $10

52 week price:
8.67
196.70

Earnings Per Share: -33.06 USD

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 50300

Market Capitalization: 177407

Links: